MLTX stock

Analysts review MoonLake Immunotherapeutics’s rating
Anna Perez
In a filing, MoonLake Immunotherapeutics revealed its Chief Financial Officer Bodenstedt Matthias acquired Company’s shares for reported $98808.0 on Oct ...

In a filing, MoonLake Immunotherapeutics revealed its Chief Financial Officer Bodenstedt Matthias acquired Company’s shares for reported $98808.0 on Oct ...